Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER

por Raskob, Gary E., Spyropoulos, Alex C., Spiro, Theodore E., Lu, Wentao, Yuan, Zhong, Levitan, Bennett, Suh, Eunyoung, Barnathan, Elliot S.
Publicado 2021

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis

por Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Peluso, Colleen, Spiro, Theodore E., De Sanctis, Yoriko, Barnathan, Elliot S., Raskob, Gary E.
Publicado 2020

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study

por Spyropoulos, Alex C., Raskob, Gary E., Spiro, Theodore E., Lu, Wentao, De Sanctis, Yoriko, Albanese, John, Mebazaa, Alexandre, Barnathan, Elliot S.
Publicado 2022

Laboratory assessment of rivaroxaban: a review

por Samama, Meyer Michel, Contant, Geneviève, Spiro, Theodore E, Perzborn, Elisabeth, Le Flem, Lena, Guinet, Céline, Gourmelin, Yves, Rohde, Gabriele, Martinoli, Jean-Luc
Publicado 2013

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling

por Solms, Alexander, Frede, Matthias, Berkowitz, Scott D., Hermanowski‐Vosatka, Anne, Kubitza, Dagmar, Mueck, Wolfgang, Spiro, Theodore E., Willmann, Stefan, Yan, Xiaoyu, Zhang, Liping, Garmann, Dirk
Publicado 2019

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

por Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Lu, Wentao, Suh, Eunyoung, Yuan, Zhong, Levitan, Bennett, Sugarmann, Chiara, De Sanctis, Yoriko, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary E.
Publicado 2019

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism

por Reinecke, Isabel, Solms, Alexander, Willmann, Stefan, Spiro, Theodore E., Peters, Gary, Weitz, Jeffrey I., Mueck, Wolfgang, Garmann, Dirk, Schmidt, Stephan, Zhang, Liping, Fox, Keith A. A., Berkowitz, Scott D.
Publicado 2020

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism

por Solms, Alexander, Willmann, Stefan, Reinecke, Isabel, Spiro, Theodore E., Peters, Gary, Weitz, Jeffrey I., Mueck, Wolfgang, Garmann, Dirk, Schmidt, Stephan, Zhang, Liping, Fox, Keith A. A., Berkowitz, Scott D.
Publicado 2020

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

por Raskob, Gary E., Spyropoulos, Alex C., Cohen, Alexander T., Weitz, Jeffrey I., Ageno, Walter, De Sanctis, Yoriko, Lu, Wentao, Xu, Jianfeng, Albanese, John, Sugarmann, Chiara, Weber, Traci, Lipardi, Concetta, Spiro, Theodore E., Barnathan, Elliot S.
Publicado 2021

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMAN...

por Mehra, Mandeep R, Vaduganathan, Muthiah, Fu, Min, Ferreira, João Pedro, Anker, Stefan D, Cleland, John G F, Lam, Carolyn S P, van Veldhuisen, Dirk J, Byra, William M, Spiro, Theodore E, Deng, Hsiaowei, Zannad, Faiez, Greenberg, Barry
Publicado 2019

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

por Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Publicado 2020

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

por Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.
Publicado 2022